Skip to content
healthcare.dev

Tizanidine

NDC 57664-503, Tizanidine, tablet, from Sun Pharmaceutical Industries, Inc..

Product NDC
57664-503
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076416
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57664-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
57664-503-18576640503181000 TABLET in 1 BOTTLE (57664-503-18)
57664-503-8957664050389150 TABLET in 1 BOTTLE (57664-503-89)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4659df31-8b89-4eff-9d86-7b7e38de416b
  • NADAC price for package 57664050318

    GET /v1/drugs/nadac/57664050318
  • NADAC price for package 57664050389

    GET /v1/drugs/nadac/57664050389

Use it

Look up 57664-503 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57664-503 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57664-503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.